Hua Gao

Hua Gao

Auto-generated profile, based on publicly available information

Hua Gao

Cancer Center and Research Institute of Intestinal Diseases, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Cell
Verified
Journal Article
Closed access
HGHua Gao
Hua Gao
GCGoutam Chakraborty
Goutam Chakraborty
ZZZhanguo Zhang
Zhanguo Zhang
IAIntissar Akalay
Intissar Akalay
MGMayur Gadiya
Mayur Gadiya
FGFilippo G. Giancotti
Filippo G. Giancotti

9 January 2024 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
DKDhiraj Kumar
Dhiraj Kumar
SGSreeharsha Gurrapu
Sreeharsha Gurrapu
YWYan Wang
Yan Wang
SBSeong-Yeon Bae
Seong-Yeon Bae
PPPoonam R. Pandey
Poonam R. Pandey
FGFilippo G. Giancotti
Filippo G. Giancotti

5 November 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HGHua Gao
Hua Gao
GCGoutam Chakraborty
Goutam Chakraborty
ALAi Ping Lee-Lim
Ai Ping Lee-Lim
KMKonstantinos J. Mavrakis
Konstantinos J. Mavrakis
HWHans-Guido Wendel
Hans-Guido Wendel
FGFilippo G. Giancotti
Filippo G. Giancotti
Significance: Insights into the mechanisms that enable disseminated cancer cells to survive during dormancy and then outgrow into life-threatening lesions may lead to the identification of novel therapeutic targets for the prevention or treatment of metastatic disease. We have developed flexible and high-throughput functional genetic screens, which enable the identification of single genetic entities that mediate metastatic reactivation of breast cancer in mice. These screens promise to facilitate the identification of the core signaling pathways that govern metastatic dormancy and reactivation.

17 February 2023 in The EMBO Journal
Verified
Journal Article
Closed access
XSXiaofei She
Xiaofei She
SSShijun Shen
Shijun Shen
GCGuang Chen
Guang Chen
YGYaqun Gao
Yaqun Gao
JMJunxian Ma
Junxian Ma
HGHua Gao
Hua Gao

14 October 2022 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
GCGuang Chen
Guang Chen
XSXiaofei She
Xiaofei She
YYYanxin Yin
Yanxin Yin
JMJunxian Ma
Junxian Ma
YGYaqun Gao
Yaqun Gao
JFJianmin Fang
Jianmin Fang

25 April 2025 in Advanced Science
Verified
Journal Article
Open access
ZDZhewen Dong
Zhewen Dong
XSXiaofei She
Xiaofei She
JMJunxian Ma
Junxian Ma
QCQian Chen
Qian Chen
YGYaqun Gao
Yaqun Gao
HGHua Gao
Hua Gao
Colorectal cancer is the second most common cause of cancer mortality worldwide, and liver metastasis is the major cause of death of patients with colorectal cancer. Dysfunctional E3 ligase activity has recently been shown to be associated with colorectal cancer. However, the key E3 ligases affecting colorectal cancer liver metastasis remain unknown. Therefore, an shRNA library targeting 156 E3 ubiquitin ligases has been used to perform an in vivo loss‐of‐function screen of a human colorectal cancer cell line in a mouse model of liver metastasis. The screen reveals that neural precursor cell expressed developmentally down‐regulated gene 4‐like (NEDD4L) knockdown promotes colorectal cancer liver metastasis. Mechanistic studies reveal that NEDD4L binds to the PPNAY motif in protein arginine methyltransferase 5 (PRMT5) and ubiquitinates PRMT5 to promote its degradation. PRMT5 degradation attenuates the arginine methylation of AKT1 to inhibit the AKT/mTOR signaling pathway. The effect of NEDD4L decreases colorectal cancer cell proliferation to suppress colonization. This study is the first to show that PRMT5 is a substrate of NEDD4L and reveals not only the metastasis‐inhibiting function of NEDD4L but also a novel mechanism by which NEDD4L prevents colorectal cancer liver metastasis. These findings may provide a new preventive strategy for liver metastasis.